Use of sacubitril/valsartan in non‐compaction cardiomyopathy: a case report

The use of sacubitril/valsartan significantly reduces death or hospitalization in patients with ejection fraction 

Saved in:
Bibliographic Details
Published in:ESC Heart Failure 2020-06, Vol.7 (3), p.1186-1189
Main Authors: Bonatto, Marcely Gimenes, Albanez, Rodrigo, Salemi, Vera Maria Cury, Moura, Lídia Zytynski
Format: Article
Language:English
Subjects:
Aminobutyrates
Angiotensin Receptor Antagonists
Biphenyl Compounds
Cardiac arrhythmia
Cardiomyopathies
Cardiomyopathy
Case Report
Case reports
Drug Combinations
Dyspnea
Ejection fraction
Electrocardiography
Female
Heart
Heart failure
Humans
Magnetic resonance imaging
Middle Aged
Mortality
non‐compaction cardiomyopathy
Patients
Reverse remodelling
Sacubitril/valsartan
Stroke Volume
Thromboembolism
Ultrasonic imaging
Valsartan
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The use of sacubitril/valsartan significantly reduces death or hospitalization in patients with ejection fraction 
ISSN:2055-5822
2055-5822
DOI:10.1002/ehf2.12713